CoChat

Iron Metabolism at the Interface between Host and Pathogen: From Nutritional Immunity to Antibacterial Development

Marchetti, Marialaura, De Bei, Omar, Bettati, Stefano, Campanini, Barbara, Kovachka, Sandra, Gianquinto, Eleonora, Spyrakis, Francesca, Ronda, Luca · 2020 · International Journal of Molecular Sciences
Cited by 97

The DOI matches its Crossref record; 101 of the 101 references it cites were found in a registry or an index.

Abstract

Nutritional immunity is a form of innate immunity widespread in both vertebrates and invertebrates. The term refers to a rich repertoire of mechanisms set up by the host to inhibit bacterial proliferation by sequestering trace minerals (mainly iron, but also zinc and manganese). This strategy, selected by evolution, represents an effective front-line defense against pathogens and has thus inspired the exploitation of iron restriction in the development of innovative antimicrobials or enhancers of antimicrobial therapy. This review focuses on the mechanisms of nutritional immunity, the strategies adopted by opportunistic human pathogen Staphylococcus aureus to circumvent it, and the impact of deletion mutants on the fitness, infectivity, and persistence inside the host. This information finally converges in an overview of the current development of inhibitors targeting the different stages of iron uptake, an as-yet unexploited target in the field of antistaphylococcal drug discovery.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/ijms21062145

Cites

101 of 101 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

1 retracted

Research works printed but not linked: 226

  1. Perutz, 1970, Stereochemistry of cooperative effects in haemoglobin: Haem–haem interaction and the problem of allostery, Nature, 228, 726, 10.1038/228726a0 · DOI · Paper page
  2. Sabio, 2017, Iron chemistry at the service of life, IUBMB Life, 69, 382, 10.1002/iub.1602 · DOI · Paper page
  3. Golonka, 2019, The iron tug-of-war between bacterial siderophores and innate immunity, J. Innate Immun., 11, 249, 10.1159/000494627 · DOI · Paper page
  4. Bullen, 1978, Role of iron in bacterial infection, Curr. Top. Microbiol. Immunol., 80, 1
  5. Jamroz, 1993, Transferrin in a cockroach: Molecular cloning, characterization, and suppression by juvenile hormone, Proc. Natl. Acad. Sci. USA, 90, 1320, 10.1073/pnas.90.4.1320 · DOI · Paper page
  6. Medzhitov, 1997, Innate immunity: Impact on the adaptive immune response, Curr. Opin. Immunol., 9, 4, 10.1016/S0952-7915(97)80152-5 · DOI · Paper page
  7. Wright, 1991, Multiple receptors for endotoxin, Curr. Opin. Immunol., 3, 83, 10.1016/0952-7915(91)90082-C · DOI · Paper page
  8. Gruenheid, 1999, Cellular and subcellular localization of the Nramp2 iron transporter in the intestinal brush border and regulation by dietary iron, Blood, 93, 4406, 10.1182/blood.V93.12.4406 · DOI · Paper page
  9. Sun, 1999, Transferrin as a metal ion mediator, Chem. Rev., 99, 2817, 10.1021/cr980430w · DOI · Paper page
  10. Wally, 2006, The crystal structure of iron-free human serum transferrin provides insight into inter-lobe communication and receptor binding, J. Biol. Chem., 281, 24934, 10.1074/jbc.M604592200 · DOI · Paper page
  11. Yang, 2012, Iron and bismuth bound human serum transferrin reveals a partially-opened conformation in the N-lobe, Sci. Rep., 2, 999, 10.1038/srep00999 · DOI
  12. Ammons, 2013, Mini-review: Lactoferrin: A bioinspired, anti-biofilm therapeutic, Biofouling, 29, 443, 10.1080/08927014.2013.773317 · DOI · Paper page
  13. Langlois, 2004, Haptoglobin polymorphisms and iron homeostasis in health and in disease, Clin. Chim. Acta, 345, 35, 10.1016/j.cccn.2004.03.016 · DOI
  14. Delanghe, 2000, Fast determination of haptoglobin phenotype and calculation of hemoglobin binding capacity using high pressure gel permeation chromatography, Clin. Chim. Acta, 291, 43, 10.1016/S0009-8981(99)00194-1 · doi:10.1016/s0009-8981(99)00194-1
  15. Cahill, 2010, Haptoglobin genotype modifies the association between dietary vitamin C and serum ascorbic acid deficiency, Am. J. Clin. Nutr., 92, 1494, 10.3945/ajcn.2010.29306 · DOI
  16. Ward, 2007, Hepcidin regulation: Ironing out the details, J. Clin. Investig., 117, 1755, 10.1172/JCI32701 · DOI · Paper page
  17. Wilson, 2006, Siderophores of Bacillus anthracis, Bacillus cereus, and Bacillus thuringiensis, Biochem. Biophys. Res. Commun., 348, 320, 10.1016/j.bbrc.2006.07.055 · DOI · Paper page
  18. DePalma, 2007, Bloodletting: Past and present, J. Am. Coll. Surg., 205, 132, 10.1016/j.jamcollsurg.2007.01.071 · DOI
  19. Haddock, 1991, Infant diet and salmonellosis, Am. J. Public Health, 81, 997, 10.2105/AJPH.81.8.997 · DOI
  20. Bilitewski, 2017, Chemical and biological aspects of nutritional immunity-perspectives for new anti-infectives that target iron uptake systems, Angew. Chemie Int. Ed., 56, 14360, 10.1002/anie.201701586 · DOI
  21. Endicott, 2017, Structural basis for xenosiderophore utilization by the human pathogen Staphylococcus aureus, ACS Infect. Dis., 3, 542, 10.1021/acsinfecdis.7b00036 · DOI
  22. Deane, 2016, Metal-pilfering pathogens, Nat. Chem. Biol., 12, 575, 10.1038/nchembio.2139 · DOI
  23. Cheng, 2011, A play in four acts: Staphylococcus aureus abscess formation, Trends Microbiol., 19, 225, 10.1016/j.tim.2011.01.007 · DOI · Paper page
  24. Cassat, 2018, Integrated molecular imaging reveals tissue heterogeneity driving host-pathogen interactions, Sci. Transl. Med., 10, eaan6361, 10.1126/scitranslmed.aan6361 · DOI · Paper page
  25. Sheldon, 2012, The iron-regulated staphylococcal lipoproteins, Front. Cell. Infect. Microbiol., 2, 41, 10.3389/fcimb.2012.00041 · DOI · Paper page
  26. Grigg, 2010, The Staphylococcus aureus siderophore receptor HtsA undergoes localized conformational changes to enclose staphyloferrin A in an arginine-rich binding pocket, J. Biol. Chem., 285, 11162, 10.1074/jbc.M109.097865 · DOI · Paper page
  27. Kobylarz, 2016, Deciphering the substrate specificity of SbnA, the enzyme catalyzing the first step in staphyloferrin B biosynthesis, Biochemistry, 55, 927, 10.1021/acs.biochem.5b01045 · DOI · Paper page
  28. Kobylarz, 2014, Synthesis of L-2,3-diaminopropionic acid, a siderophore and antibiotic precursor, Chem. Biol., 21, 379, 10.1016/j.chembiol.2013.12.011 · DOI
  29. Kobylarz, 2014, SbnG, a citrate synthase in Staphylococcus aureus, J. Biol. Chem., 289, 33797, 10.1074/jbc.M114.603175 · DOI
  30. Verstraete, 2018, SbnI is a free serine kinase that generates O -phospho-l-serine for staphyloferrin B biosynthesis in Staphylococcus aureus, J. Biol. Chem., 293, 6147, 10.1074/jbc.RA118.001875 · DOI · Paper page
  31. Tang, 2019, Structural insights into substrate recognition and activity regulation of the key decarboxylase SbnH in staphyloferrin B biosynthesis, J. Mol. Biol., 431, 4868, 10.1016/j.jmb.2019.10.009 · DOI
  32. Podkowa, 2014, Crystal and solution structure analysis of FhuD2 from Staphylococcus aureus in multiple unliganded conformations and bound to ferrioxamine-B, Biochemistry, 53, 2017, 10.1021/bi401349d · DOI · Paper page
  33. Mariotti, 2013, Structural and functional characterization of the Staphylococcus aureus virulence factor and vaccine candidate FhuD2, Biochem. J., 449, 683, 10.1042/BJ20121426 · DOI · Paper page
  34. Kobylarz, 2017, Iron uptake oxidoreductase (IruO) uses a flavin adenine dinucleotide semiquinone intermediate for iron-siderophore reduction, ACS Chem. Biol., 12, 1778, 10.1021/acschembio.7b00203 · DOI · Paper page
  35. Song, 1996, Structure of Staphylococcal alpha-hemolysin, a heptameric transmembrane pore, Science, 274, 1859, 10.1126/science.274.5294.1859 · DOI · Paper page
  36. Yamashita, 2011, Crystal structure of the octameric pore of staphylococcal gamma-hemolysin reveals the beta-barrel pore formation mechanism by two components, Proc. Natl. Acad. Sci. USA, 108, 17314, 10.1073/pnas.1110402108 · DOI · Paper page
  37. Nocadello, 2016, Crystal structures of the components of the Staphylococcus aureus leukotoxin ED, Acta Crystallogr. Sect. D Struct. Biol., 72, 113, 10.1107/S2059798315023207 · DOI
  38. Zong, 2004, Crystal structures of Staphylococcus aureus sortase A and its substrate complex, J. Biol. Chem., 279, 31383, 10.1074/jbc.M401374200 · DOI · Paper page
  39. Zhang, 2004, Structures of sortase B from Staphylococcus aureus and Bacillus anthracis reveal catalytic amino acid triad in the active site, Structure, 12, 1147, 10.1016/j.str.2004.06.001 · DOI
  40. Jacobitz, 2014, Structural and computational studies of the Staphylococcus aureus sortase B-substrate complex reveal a substrate-stabilized oxyanion hole, J. Biol. Chem., 289, 8891, 10.1074/jbc.M113.509273 · DOI · Paper page
  41. Dickson, 2015, The structure of haemoglobin bound to the haemoglobin receptor IsdH from Staphylococcus aureus shows disruption of the native α-globin haem pocket, Acta Crystallogr. Sect. D Biol. Crystallogr., 71, 1295, 10.1107/S1399004715005817 · DOI
  42. Bowden, 2018, Structure–function analyses reveal key features in Staphylococcus aureus IsdB-associated unfolding of the heme-binding pocket of human hemoglobin, J. Biol. Chem., 293, 177, 10.1074/jbc.M117.806562 · DOI · Paper page
  43. Grigg, 2007, Heme coordination by Staphylococcus aureus IsdE, J. Biol. Chem., 282, 28815, 10.1074/jbc.M704602200 · DOI · Paper page
  44. Challis, 2005, A widely distributed bacterial pathway for siderophore biosynthesis independent of nonribosomal peptide synthetases, ChemBioChem, 6, 601, 10.1002/cbic.200400283 · DOI · Paper page
  45. Collins, 1962, The effect of growth conditions on oxidative and dehydrogenase activity in Staphylococcus aureus, J. Gen. Microbiol., 29, 531, 10.1099/00221287-29-3-531 · DOI · Paper page
  46. Hannauer, 2015, Involvement of major facilitator superfamily proteins SfaA and SbnD in staphyloferrin secretion in Staphylococcus aureus, FEBS Lett., 589, 730, 10.1016/j.febslet.2015.02.002 · DOI · Paper page
  47. Nakaminami, 2017, Efflux transporter of siderophore staphyloferrin A in Staphylococcus aureus contributes to bacterial fitness in abscesses and epithelial cells, Infect. Immun., 85, 1, 10.1128/IAI.00358-17 · DOI
  48. Madsen, 2015, Chemical synthesis of staphyloferrin B affords insight into the molecular structure, iron chelation, and biological activity of a polycarboxylate siderophore deployed by the human pathogen Staphylococcus aureus, J. Am. Chem. Soc., 137, 9117, 10.1021/jacs.5b04557 · DOI · Paper page
  49. Beasley, F.C., Cheung, J., and Heinrichs, D.E. (2011). Mutation of L-2,3-diaminopropionic acid synthase genes blocks staphyloferrin B synthesis in Staphylococcus aureus. BMC Microbiol., 11. · DOI · Paper page
  50. Heinrichs, 1999, Identification and characterization of SirA, an iron-regulated protein from Staphylococcus aureus, J. Bacteriol., 181, 1436, 10.1128/JB.181.5.1436-1443.1999 · DOI · Paper page
  51. Hannauer, 2015, Involvement of reductases IruO and NtrA in iron acquisition by Staphylococcus aureus, Mol. Microbiol., 96, 1192, 10.1111/mmi.13000 · DOI · Paper page
  52. Courcol, 1997, Siderophore production by Staphylococcus aureus and identification of iron-regulated proteins, Infect. Immun., 65, 1944, 10.1128/iai.65.5.1944-1948.1997 · DOI · Paper page
  53. Fojcik, 2018, Independent and cooperative regulation of staphylopine biosynthesis and trafficking by Fur and Zur, Mol. Microbiol., 108, 159, 10.1111/mmi.13927 · DOI · Paper page
  54. Song, 2018, Mechanistic insights into staphylopine-mediated metal acquisition, Proc. Natl. Acad. Sci. USA, 115, 3942, 10.1073/pnas.1718382115 · DOI · Paper page
  55. Chen, 2019, Intracellular accumulation of staphylopine impairs the fitness of Staphylococcus aureus cntE mutant, FEBS Lett., 593, 1213, 10.1002/1873-3468.13396 · DOI
  56. Neumann, 2017, Metal homeostasis in infectious disease: Recent advances in bacterial metallophores and the human metal-withholding response, Curr. Opin. Chem. Biol., 37, 10, 10.1016/j.cbpa.2016.09.012 · DOI · Paper page
  57. Brock, 1983, The effect of desferrioxamine on the growth of Staphylococcus aureus, Yersinia enterocolitica and Streptococcus faecalis in human serum: Uptake of desferrioxamine-bound iron, FEMS Microbiol. Lett., 20, 439, 10.1111/j.1574-6968.1983.tb00164.x · DOI · Paper page
  58. Sebulsky, 2003, The role of FhuD2 in iron(III)-hydroxamate transport in Staphylococcus aureus, J. Biol. Chem., 278, 49890, 10.1074/jbc.M305073200 · DOI · Paper page
  59. Mishra, 2012, Staphylococcus aureus FhuD2 Is involved in the early phase of staphylococcal dissemination and generates protective immunity in mice, J. Infect. Dis., 206, 1041, 10.1093/infdis/jis463 · DOI · Paper page
  60. Sebulsky, 2001, Identification and characterization of fhuD1 and fhuD2, two genes involved in iron-hydroxamate uptake in Staphylococcus aureus, J. Bacteriol., 183, 4994, 10.1128/JB.183.17.4994-5000.2001 · DOI · Paper page
  61. Morrissey, 2000, Molecular cloning and analysis of a putative siderophore ABC transporter from Staphylococcus aureus, Infect. Immun., 68, 6281, 10.1128/IAI.68.11.6281-6288.2000 · DOI · Paper page
  62. Miethke, 2006, Ferri-bacillibactin uptake and hydrolysis in Bacillus subtilis, Mol. Microbiol., 61, 1413, 10.1111/j.1365-2958.2006.05321.x · DOI · Paper page
  63. Abergel, 2009, Enzymatic hydrolysis of trilactone siderophores: Where chiral recognition occurs in enterobactin and bacillibactin iron transport, J. Am. Chem. Soc., 131, 12682, 10.1021/ja903051q · DOI · Paper page
  64. Lin, 2005, In vitro characterization of salmochelin and enterobactin trilactone hydrolases IroD, IroE, and Fes, J. Am. Chem. Soc., 127, 11075, 10.1021/ja0522027 · DOI · Paper page
  65. Cheung, 1994, Regulation of alpha- and beta-hemolysins by the sar locus of Staphylococcus aureus, J. Bacteriol., 176, 580, 10.1128/jb.176.3.580-585.1994 · DOI · Paper page
  66. Novick, 2003, Autoinduction and signal transduction in the regulation of staphylococcal virulence, Mol. Microbiol., 48, 1429, 10.1046/j.1365-2958.2003.03526.x · DOI · Paper page
  67. Venkatasubramaniam, A., Kanipakala, T., Ganjbaksh, N., Mehr, R., Mukherjee, I., Krishnan, S., Bae, T., Aman, M.J., and Adhikari, R.P. (2018). A critical role for HlgA in Staphylococcus aureus pathogenesis revealed by a switch in the SaeRS two-component regulatory system. Toxins (Basel)., 10. · DOI
  68. Bhakdil, 1991, Alpha-toxin of Staphylococcus aureus, Microbiol. Rev., 55, 733, 10.1128/mr.55.4.733-751.1991 · doi:10.1128/mr.55.4.733-751.1991 · Paper page
  69. Nilsson, 1999, Alpha-toxin and gamma-toxin jointly promote Staphylococcus aureus virulence in murine septic arthritis, Infect. Immun., 67, 1045, 10.1128/IAI.67.3.1045-1049.1999 · DOI · Paper page
  70. Kielian, 2001, Diminished virulence of an alpha-toxin mutant of Staphylococcus aureus in experimental brain abscesses, Infect. Immun., 69, 6902, 10.1128/IAI.69.11.6902-6911.2001 · DOI · Paper page
  71. Malachowa, N., Whitney, A.R., Kobayashi, S.D., Sturdevant, D.E., Kennedy, A.D., Braughton, K.R., Shabb, D.W., Diep, B.A., Chambers, H.F., and Otto, M. (2011). Global changes in Staphylococcus aureus gene expression in human blood. PLoS ONE, 6. · DOI · Paper page
  72. Yoong, 2015, Counter inhibition between leukotoxins attenuates Staphylococcus aureus virulence, Nat. Commun., 6, 8125, 10.1038/ncomms9125 · DOI · Paper page
  73. Fraunholz, 2012, Intracellular staphylococcus aureus: Live-in and let die, Front. Cell. Infect. Microbiol., 2, 43, 10.3389/fcimb.2012.00043 · DOI · Paper page
  74. Strobel, 2016, Post-invasion events after infection with Staphylococcus aureus are strongly dependent on both the host cell type and the infecting S. aureus strain, Clin. Microbiol. Infect., 22, 799, 10.1016/j.cmi.2016.06.020 · DOI · Paper page
  75. McCarthy, 2013, Staphylococcus aureus innate immune evasion is lineage-specific: A bioinfomatics study, Infect. Genet. Evol., 19, 7, 10.1016/j.meegid.2013.06.012 · DOI
  76. Schneewind, 1995, Structure of the cell wall anchor of surface proteins in Staphylococcus aureus, Science, 268, 103, 10.1126/science.7701329 · DOI · Paper page
  77. Taylor, 2002, Transferrin binding in Staphylococcus aureus: Involvement of a cell wall-anchored protein, Mol. Microbiol., 43, 1603, 10.1046/j.1365-2958.2002.02850.x · DOI · Paper page
  78. Clarke, 2004, IsdA of Staphylococcus aureus is a broad spectrum, iron-regulated adhesin, Mol. Microbiol., 51, 1509, 10.1111/j.1365-2958.2003.03938.x · DOI · Paper page
  79. Abe, 2012, Mapping ultra-weak protein-protein interactions between heme transporters of Staphylococcus aureus, J. Biol. Chem., 287, 16477, 10.1074/jbc.M112.346700 · DOI · Paper page
  80. Tiedemann, 2012, Multiprotein heme shuttle pathway in Staphylococcus aureus: Iron-regulated surface determinant cog-wheel kinetics, J. Am. Chem. Soc., 134, 16578, 10.1021/ja305115y · DOI · Paper page
  81. Takayama, 2011, Electronic properties of the highly ruffled heme bound to the heme degrading enzyme IsdI, Proc. Natl. Acad. Sci. USA, 108, 13071, 10.1073/pnas.1101459108 · DOI · Paper page
  82. Reniere, 2008, Staphylococcus aureus haem oxygenases are differentially regulated by iron and haem, Mol. Microbiol., 69, 1304, 10.1111/j.1365-2958.2008.06363.x · DOI · Paper page
  83. Verstraete, 2019, The heme-sensitive regulator SbnI has a bifunctional role in staphyloferrin B production by Staphylococcus aureus, J. Biol. Chem., 294, 11622, 10.1074/jbc.RA119.007757 · DOI · Paper page
  84. Loutet, 2013, IruO is a reductase for heme degradation by IsdI and IsdG proteins in Staphylococcus aureus, J. Biol. Chem., 288, 25749, 10.1074/jbc.M113.470518 · DOI · Paper page
  85. Foster, 2014, Adhesion, invasion and evasion: The many functions of the surface proteins of Staphylococcus aureus, Nat. Rev. Microbiol., 12, 49, 10.1038/nrmicro3161 · DOI · Paper page
  86. Clarke, 2008, IsdA protects Staphylococcus aureus against the bactericidal protease activity of apolactoferrin, Infect. Immun., 76, 1518, 10.1128/IAI.01530-07 · DOI · Paper page
  87. Speziale, 2014, Protein-based biofilm matrices in Staphylococci, Front. Cell. Infect. Microbiol., 4, 1, 10.3389/fcimb.2014.00171 · DOI · Paper page
  88. Missineo, 2014, IsdC from Staphylococcus lugdunensis induces biofilm formation under low-iron growth conditions, Infect. Immun., 82, 2448, 10.1128/IAI.01542-14 · DOI · Paper page
  89. Miajlovic, 2010, Direct interaction of iron-regulated surface determinant IsdB of Staphylococcus aureus with the GPIIb/IIIa receptor on platelets, Microbiology, 156, 920, 10.1099/mic.0.036673-0 · DOI · Paper page
  90. Zapotoczna, 2013, Iron-regulated surface determinant B (IsdB) promotes Staphylococcus aureus adherence to and internalization by non-phagocytic human cells, Cell. Microbiol., 15, 1026, 10.1111/cmi.12097 · DOI · Paper page
  91. Biswas, 2009, Role of the twin-arginine translocation pathway in Staphylococcus, J. Bacteriol., 191, 5921, 10.1128/JB.00642-09 · DOI · Paper page
  92. Turlin, E., Débarbouillé, M., Augustyniak, K., Gilles, A.-M., and Wandersman, C. (2013). Staphylococcus aureus FepA and FepB proteins drive heme iron utilization in Escherichia coli. PLoS ONE, 8. · DOI · Paper page
  93. Heuck, 2009, Bacteria capture iron from heme by keeping tetrapyrrol skeleton intact, Proc. Natl. Acad. Sci. USA, 106, 11719, 10.1073/pnas.0903842106 · DOI · Paper page
  94. Reniere, 2007, Intracellular metalloporphyrin metabolism in Staphylococcus aureus, BioMetals, 20, 333, 10.1007/s10534-006-9032-0 · DOI · Paper page
  95. Tiburzi, 2009, Is the host heme incorporated in microbial heme-proteins?, IUBMB Life, 61, 80, 10.1002/iub.123 · DOI
  96. Bernhardt, 2016, Costs of life - dynamics of the protein inventory of Staphylococcus aureus during anaerobiosis, Sci. Rep., 6, 28172, 10.1038/srep28172 · DOI
  97. Nobre, 2013, Effect of combined oxidative and nitrosative stresses on Staphylococcus aureus transcriptome, Appl. Microbiol. Biotechnol., 97, 2563, 10.1007/s00253-013-4730-3 · DOI
  98. Mazmanian, 2000, Staphylococcus aureus sortase mutants defective in the display of surface proteins and in the pathogenesis of animal infections, Proc. Natl. Acad. Sci. USA, 97, 5510, 10.1073/pnas.080520697 · DOI · Paper page
  99. Chen, 2014, Role of sortase A in the pathogenesis of Staphylococcus aureus-induced mastitis in mice, FEMS Microbiol. Lett., 351, 95, 10.1111/1574-6968.12354 · DOI
  100. Jonsson, 2003, The role of Staphylococcus aureus sortase A and sortase B in murine arthritis, Microbes Infect., 5, 775, 10.1016/S1286-4579(03)00143-6 · DOI · Paper page
  101. Johnson, 2011, Fur is required for the activation of virulence gene expression through the induction of the sae regulatory system in Staphylococcus aureus, Int. J. Med. Microbiol., 301, 44, 10.1016/j.ijmm.2010.05.003 · DOI · Paper page
  102. Bogos, 2014, Perturbation of iron homeostasis promotes the evolution of antibiotic resistance, Mol. Biol. Evol., 31, 2793, 10.1093/molbev/msu223 · DOI
  103. Allard, 2006, Transcriptional modulation of some Staphylococcus aureus iron-regulated genes during growth in vitro and in a tissue cage model in vivo, Microbes Infect., 8, 1679, 10.1016/j.micinf.2006.01.022 · DOI
  104. Lojek, 2018, Fur regulation of Staphylococcus aureus heme oxygenases is required for heme homeostasis, Int. J. Med. Microbiol., 308, 582, 10.1016/j.ijmm.2018.01.009 · DOI
  105. Porcheron, 2015, Interplay between iron homeostasis and virulence: Fur and RyhB as major regulators of bacterial pathogenicity, Vet. Microbiol., 179, 2, 10.1016/j.vetmic.2015.03.024 · DOI · Paper page
  106. Liu, 2018, Assessment of bona fide sRNAs in Staphylococcus aureus, Front. Microbiol., 9, 1
  107. Mäder, U., Nicolas, P., Depke, M., Pané-Farré, J., Debarbouille, M., van der Kooi-Pol, M.M., Guérin, C., Dérozier, S., Hiron, A., and Jarmer, H. (2016). Staphylococcus aureus transcriptome architecture: From laboratory to infection-mimicking conditions. PLOS Genet., 12. · DOI · Paper page
  108. Shahmirzadi, 2016, Evaluation of Staphylococcus aureus lipoproteins: Role in nutritional acquisition and pathogenicity, Front. Microbiol., 7, 1, 10.3389/fmicb.2016.01404 · DOI
  109. Williams, 2006, Host defenses against Staphylococcus aureus infection require recognition of bacterial lipoproteins, Proc. Natl. Acad. Sci. USA, 103, 13831, 10.1073/pnas.0603072103 · DOI · Paper page
  110. Hashimoto, 2006, Lipoprotein is a predominant Toll-like receptor 2 ligand in Staphylococcus aureus cell wall components, Int. Immunol., 18, 355, 10.1093/intimm/dxh374 · DOI · Paper page
  111. Nguyen, 2017, Intercellular communication for innate immunity, Mol. Immunol., 86, 16, 10.1016/j.molimm.2016.10.002 · DOI
  112. Schmaler, 2009, Lipoproteins in Staphylococcus aureus mediate inflammation by TLR2 and iron-dependent growth in vivo, J. Immunol., 182, 7110, 10.4049/jimmunol.0804292 · DOI · Paper page
  113. Recsei, 1986, Regulation of exoprotein gene expression in Staphylococcus aureus by agr, Mol. Gen. Genet. MGG, 202, 58, 10.1007/BF00330517 · DOI · Paper page
  114. Xiong, 2006, Regulation of Staphylococcus aureus α-toxin gene (hla) expression by agr, sarA, and sae in vitro and in experimental infective endocarditis, J. Infect. Dis., 194, 1267, 10.1086/508210 · DOI · Paper page
  115. Novick, 1995, Theagr P2 operon: An autocatalytic sensory transduction system in Staphylococcus aureus, Mol. Gen. Genet. MGG, 248, 446, 10.1007/BF02191645 · DOI · Paper page
  116. Koenig, 2004, Staphylococcus aureus AgrA binding to the RNAIII-agr regulatory region, J. Bacteriol., 186, 7549, 10.1128/JB.186.22.7549-7555.2004 · DOI · Paper page
  117. Reyes, 2011, Coordinated regulation by AgrA, SarA, and SarR to control agr expression in Staphylococcus aureus, J. Bacteriol., 193, 6020, 10.1128/JB.05436-11 · DOI · Paper page
  118. Sidote, 2008, Structure of the Staphylococcus aureus AgrA LytTR domain bound to DNA reveals a beta fold with an unusual mode of binding, Structure, 16, 727, 10.1016/j.str.2008.02.011 · DOI
  119. Leonard, 2012, Identification of a hydrophobic cleft in the LytTR domain of AgrA as a locus for small molecule interactions that inhibit DNA binding, Biochemistry, 51, 10035, 10.1021/bi3011785 · DOI
  120. Bezar, 2019, Drug-like fragments inhibit agr-mediated virulence expression in Staphylococcus aureus, Sci. Rep., 9, 6786, 10.1038/s41598-019-42853-z · DOI
  121. Khodaverdian, 2013, Discovery of antivirulence agents against methicillin-resistant Staphylococcus aureus, Antimicrob. Agents Chemother., 57, 3645, 10.1128/AAC.00269-13 · DOI
  122. Yu, 2014, Combinatorial synthesis and in vitro evaluation of a biaryl hydroxyketone library as antivirulence agents against MRSA, ACS Comb. Sci., 16, 85, 10.1021/co400142t · DOI
  123. Kuo, 2015, Novel quorum-quenching agents promote methicillin-resistant Staphylococcus aureus (MRSA) wound healing and sensitize MRSA to β-lactam antibiotics, Antimicrob. Agents Chemother., 59, 1512, 10.1128/AAC.04767-14 · DOI
  124. Greenberg, 2018, Small-molecule AgrA inhibitors F12 and F19 act as antivirulence agents against gram-positive pathogens, Sci. Rep., 8, 14578, 10.1038/s41598-018-32829-w · DOI
  125. Sully, E.K., Malachowa, N., Elmore, B.O., Alexander, S.M., Femling, J.K., Gray, B.M., DeLeo, F.R., Otto, M., Cheung, A.L., and Edwards, B.S. (2014). Selective chemical inhibition of agr quorum sensing in Staphylococcus aureus promotes host defense with minimal impact on resistance. PLoS Pathog., 10. · DOI · Paper page
  126. Figueroa, 2014, Polyhydroxyanthraquinones as quorum sensing inhibitors from the guttates of Penicillium restrictum and their analysis by desorption electrospray ionization mass spectrometry, J. Nat. Prod., 77, 1351, 10.1021/np5000704 · DOI · Paper page
  127. Daly, 2015, ω-Hydroxyemodin limits Staphylococcus aureus quorum sensing-mediated pathogenesis and inflammation, Antimicrob. Agents Chemother., 59, 2223, 10.1128/AAC.04564-14 · DOI · Paper page
  128. Parlet, 2019, Apicidin attenuates MRSA virulence through quorum-sensing inhibition and enhanced host defense, Cell Rep., 27, 187, 10.1016/j.celrep.2019.03.018 · DOI
  129. Ji, 1997, Bacterial interference caused by autoinducing peptide variants, Science, 276, 2027, 10.1126/science.276.5321.2027 · DOI · Paper page
  130. Mayville, 1999, Structure-activity analysis of synthetic autoinducing thiolactone peptides from Staphylococcus aureus responsible for virulence, Proc. Natl. Acad. Sci. USA, 96, 1218, 10.1073/pnas.96.4.1218 · DOI · Paper page
  131. Stacy, 2013, Highly potent inhibitors of quorum sensing in Staphylococcus aureus revealed through a systematic synthetic study of the group-III autoinducing peptide, J. Am. Chem. Soc., 135, 7869, 10.1021/ja3112115 · DOI · Paper page
  132. Ivancic, 2013, Structural characterization of native autoinducing peptides and abiotic analogues reveals key features essential for activation and inhibition of an AgrC quorum sensing receptor in Staphylococcus aureus, J. Am. Chem. Soc., 135, 18436, 10.1021/ja407533e · DOI · Paper page
  133. Vasquez, 2017, Simplified AIP-II peptidomimetics are potent inhibitors of Staphylococcus aureus AgrC quorum sensing receptors, ChemBioChem, 18, 413, 10.1002/cbic.201600516 · DOI · Paper page
  134. Vasquez, 2019, Simplified autoinducing peptide mimetics with single-nanomolar activity against the Staphylococcus aureus AgrC quorum sensing receptor, ACS Infect. Dis., 5, 484, 10.1021/acsinfecdis.9b00002 · DOI · Paper page
  135. Niu, 2013, Molecular insight into the inhibition mechanism of cyrtominetin to α-hemolysin by molecular dynamics simulation, Eur. J. Med. Chem., 62, 320, 10.1016/j.ejmech.2013.01.008 · DOI
  136. Dong, J., Qiu, J., Zhang, Y., Lu, C., Dai, X., Wang, J., Li, H., Wang, X., Tan, W., and Luo, M. (2013). Oroxylin a inhibits hemolysis via hindering the self-assembly of α-hemolysin heptameric transmembrane pore. PLoS Comput. Biol., 9. · DOI
  137. Qiu, J., Wang, D., Zhang, Y., Dong, J., Wang, J., and Niu, X. (2013). Molecular modeling reveals the novel inhibition mechanism and binding mode of three natural compounds to staphylococcal α-hemolysin. PLoS ONE, 8. · DOI
  138. Qiu, 2013, Bacillus anthracis cell wall peptidoglycan but not lethal or edema toxins produces changes consistent with disseminated intravascular coagulation in a rat model, J. Infect. Dis., 208, 978, 10.1093/infdis/jit247 · doi:10.1093/infdis/jit247
  139. Rani, 2014, Inhibition of pore formation by blocking the assembly of Staphylococcus aureus α-hemolysin through a novel peptide inhibitor: An in silco approach, Int. J. Pept. Res. Ther., 20, 575, 10.1007/s10989-014-9424-x · DOI
  140. Ragle, 2010, Prevention and treatment of Staphylococcus aureus pneumonia with beta-cyclodextrin derivative, Antimicrob. Agents Chemother., 54, 298, 10.1128/AAC.00973-09 · DOI
  141. Karginov, 2007, Inhibition of S. aureus α-hemolysin and B. anthracis lethal toxin by β-cyclodextrin derivatives, Bioorg. Med. Chem., 15, 5424, 10.1016/j.bmc.2007.05.058 · DOI
  142. McCormick, 2009, Chemical inhibition of alpha-toxin, a key corneal virulence factor of Staphylococcus aureus, Investig. Ophthalmol. Vis. Sci., 50, 2848, 10.1167/iovs.08-3157 · DOI
  143. Teixeira, 2009, Interaction of heparins and dextran sulfates with a mesoscopic protein nanopore, Biophys. J., 97, 2894, 10.1016/j.bpj.2009.09.019 · DOI
  144. Melo, 2016, Inhibition of the hemolytic activity caused by Staphylococcus aureus alpha-hemolysin through isatin-Schiff copper(II) complexes, FEMS Microbiol. Lett., 363, fnv207, 10.1093/femsle/fnv207 · doi:10.1093/femsle/fnv207
  145. Kim, 2009, Effect of iron-chelator deferiprone on the in vitro growth of staphylococci, J. Korean Med. Sci., 24, 289, 10.3346/jkms.2009.24.2.289 · DOI · Paper page
  146. Richter, 2017, A topical hydrogel with deferiprone and gallium-protoporphyrin targets bacterial iron metabolism and has antibiofilm activity, Antimicrob. Agents Chemother., 61, 1, 10.1128/AAC.00481-17 · DOI · Paper page
  147. Richter, 2017, Deferiprone and gallium-protoporphyrin have the capacity to potentiate the activity of antibiotics in Staphylococcus aureus small colony variants, Front. Cell. Infect. Microbiol., 7, 1, 10.3389/fcimb.2017.00280 · DOI
  148. Zhou, 2014, In vitro antimicrobial activity of hydroxypyridinone hexadentate-based dendrimeric chelators alone and in combination with norfloxacin, FEMS Microbiol. Lett., 355, 124, 10.1111/1574-6968.12465 · DOI
  149. Zhou, 2015, Hexadentate 3-hydroxypyridin-4-ones with high iron(III) affinity: Design, synthesis and inhibition on methicillin resistant Staphylococcus aureus and Pseudomonas strains, Eur. J. Med. Chem., 94, 8, 10.1016/j.ejmech.2015.02.050 · DOI
  150. Ang, 2018, DIBI, a 3-hydroxypyridin-4-one chelator iron-binding polymer with enhanced antimicrobial activity, Medchemcomm, 9, 1206, 10.1039/C8MD00192H · DOI
  151. Li, 2016, Macromolecular iron-chelators via RAFT-polymerization for the inhibition of methicillin-resistant Staphylococcus aureus growth, Polymer (Guildf)., 87, 64, 10.1016/j.polymer.2016.01.073 · DOI
  152. Savage, 2018, Novel iron-chelator DIBI inhibits Staphylococcus aureus growth, suppresses experimental MRSA infection in mice and enhances the activities of diverse antibiotics in vitro, Front. Microbiol., 9, 1811, 10.3389/fmicb.2018.01811 · DOI
  153. Workman, 2016, Synthesis of novel iron(III) chelators based on triaza macrocycle backbone and 1-hydroxy-2(H)-pyridin-2-one coordinating groups and their evaluation as antimicrobial agents, J. Inorg. Biochem., 160, 49, 10.1016/j.jinorgbio.2016.04.018 · DOI
  154. Braun, 2009, Sideromycins: Tools and antibiotics, BioMetals, 22, 3, 10.1007/s10534-008-9199-7 · DOI · Paper page
  155. Sloderbach, 2014, Siderophore–drug complexes: Potential medicinal applications of the ‘Trojan horse’ strategy, Trends Pharmacol. Sci., 35, 442, 10.1016/j.tips.2014.06.007 · DOI · Paper page
  156. Heinisch, 2009, Siderophores as drug delivery agents: Application of the “Trojan Horse” strategy, BioMetals, 22, 615, 10.1007/s10534-009-9219-2 · DOI · Paper page
  157. Reynolds, 1947, Grisein, a new antibiotic produced by a strain of Streptomyces griseus, Exp. Biol. Med., 64, 50, 10.3181/00379727-64-15695 · DOI · Paper page
  158. Benz, 1982, Constitution of the deferriform of the albomycins δ1, δ2, and ε, Angew. Chemie Int. Ed. English, 21, 527, 10.1002/anie.198205271 · DOI · Paper page
  159. Gause, 1955, Recent studies on albomycin, a new antibiotic, Br. Med. J., 2, 1177, 10.1136/bmj.2.4949.1177 · DOI · Paper page
  160. Aretz, 1995, Salmycin A-D, antibiotika aus Streptomyces violaceus, DSM 8286, mit siderophor-aminoglycosid-struktur, Helv. Chim. Acta, 78, 46, 10.1002/hlca.19950780105 · DOI · Paper page
  161. Bunet, 2006, Identification of genes involved in siderophore transport in Streptomyces coelicolor A3(2), FEMS Microbiol. Lett., 262, 57, 10.1111/j.1574-6968.2006.00362.x · DOI
  162. Ballouche, 2009, Iron metabolism: A promising target for antibacterial strategies, Recent Pat. Antiinfect. Drug Discov., 4, 190, 10.2174/157489109789318514 · DOI · Paper page
  163. Wencewicz, 2013, Trihydroxamate siderophore–fluoroquinolone conjugates are selective sideromycin antibiotics that target Staphylococcus aureus, Bioconjug. Chem., 24, 473, 10.1021/bc300610f · DOI · Paper page
  164. Braun, 1999, Active transport of siderophore-mimicking antibacterials across the outer membrane, Drug Resist. Updat., 2, 363, 10.1054/drup.1999.0107 · DOI
  165. Pugsley, 1987, Highly efficient uptake of a rifamycin derivative via the FhuA-TonB-dependent uptake route in Escherichia coli, Microbiology, 133, 3505, 10.1099/00221287-133-12-3505 · DOI · Paper page
  166. Negash, K.H., Norris, J.K.S., and Hodgkinson, J.T. (2019). Siderophore–antibiotic conjugate design: New drugs for bad bugs?. Molecules, 24. · DOI · Paper page
  167. Neumann, 2018, Esterase-catalyzed siderophore hydrolysis activates an enterobactin–ciprofloxacin conjugate and confers targeted antibacterial activity, J. Am. Chem. Soc., 140, 5193, 10.1021/jacs.8b01042 · DOI · Paper page
  168. Lin, 2019, Synthetic sideromycins (skepticism and optimism): Selective generation of either broad or narrow spectrum gram-negative antibiotics, BioMetals, 32, 425, 10.1007/s10534-019-00192-6 · DOI
  169. Kong, 2019, An overview of recent progress in siderophore-antibiotic conjugates, Eur. J. Med. Chem., 182, 111615, 10.1016/j.ejmech.2019.111615 · DOI
  170. Zähner, H., Diddens, H., Keller-Schierlein, W., and Nägeli, H.U. (1977). Some experiments with semisynthetic sideromycins. Jpn. J. Antibiot., 201–206. Available online: https://europepmc.org/article/med/612705.
  171. Ghosh, 1996, Synthesis and in vitro antibacterial activity of spermidine-based mixed catechol- and hydroxamate-containing siderophore-vancomycin conjugates, Bioorganic Med. Chem., 4, 43, 10.1016/0968-0896(95)00161-1 · DOI · Paper page
  172. Ghosh, 1995, Design, synthesis, and biological evaluation of isocyanurate-based antifungal and macrolide antibiotic conjugates: Iron transport-mediated drug delivery, Bioorg. Med. Chem., 3, 1519, 10.1016/0968-0896(95)00134-3 · DOI · Paper page
  173. Milner, 2013, Staphyloferrin A as siderophore-component in fluoroquinolone-based Trojan horse antibiotics, Org. Biomol. Chem., 11, 3461, 10.1039/c3ob40162f · DOI · Paper page
  174. Ji, 2012, Chemical syntheses and in vitro antibacterial activity of two desferrioxamine B-ciprofloxacin conjugates with potential esterase and phosphatase triggered drug release linkers, Bioorg. Med. Chem., 20, 3828, 10.1016/j.bmc.2012.04.034 · DOI · Paper page
  175. Ji, 2015, Siderophore–fluoroquinolone conjugates containing potential reduction-triggered linkers for drug release: Synthesis and antibacterial activity, BioMetals, 28, 541, 10.1007/s10534-015-9830-3 · DOI
  176. DeLeon, 2009, Gallium maltolate treatment eradicates Pseudomonas aeruginosa infection in thermally injured mice, Antimicrob. Agents Chemother., 53, 1331, 10.1128/AAC.01330-08 · DOI · Paper page
  177. Bonchi, 2014, Repurposing of gallium-based drugs for antibacterial therapy, BioFactors, 40, 303, 10.1002/biof.1159 · DOI · Paper page
  178. Bernstein, 2015, Drug repurposing as an alternative for the treatment of recalcitrant bacterial infections, Front. Microbiol., 6, 1
  179. Baldoni, 2010, In vitro activity of gallium maltolate against staphylococci in logarithmic, stationary, and biofilm growth phases: Comparison of conventional and calorimetric susceptibility testing methods, Antimicrob. Agents Chemother., 54, 157, 10.1128/AAC.00700-09 · DOI
  180. Kelson, 2013, Gallium-based anti-infectives: Targeting microbial iron-uptake mechanisms, Curr. Opin. Pharmacol., 13, 707, 10.1016/j.coph.2013.07.001 · DOI · Paper page
  181. Bernstein, 1998, Mechanisms of therapeutic activity for gallium, Pharmacol. Rev., 50, 665
  182. Emery, 1986, Exchange of iron by gallium in siderophores, Biochemistry, 25, 4629, 10.1021/bi00364a026 · DOI · Paper page
  183. Kaneko, 2007, The transition metal gallium disrupts Pseudomonas aeruginosa iron metabolism and has antimicrobial and antibiofilm activity, J. Clin. Investig., 117, 877, 10.1172/JCI30783 · DOI · Paper page
  184. Richter, 2017, Innovative approaches to treat Staphylococcus aureus biofilm-related infections, Essays Biochem., 61, 61, 10.1042/EBC20160056 · DOI
  185. Minandri, 2014, Promises and failures of gallium as an antibacterial agent, Future Microbiol., 9, 379, 10.2217/fmb.14.3 · DOI
  186. Bernstein, 2000, Chemistry and pharmacokinetics of gallium maltolate, a compound with high oral gallium bioavailability, Met. Based. Drugs, 7, 33, 10.1155/MBD.2000.33 · DOI · Paper page
  187. Rodriguez, 2008, Utilization of Fe3+-acinetoferrin analogs as an iron source by Mycobacterium tuberculosis, BioMetals, 21, 93, 10.1007/s10534-007-9096-5 · DOI
  188. Richter, 2016, Mind “De GaPP”: In vitro efficacy of deferiprone and gallium-protoporphyrin against Staphylococcus aureus biofilms, Int. Forum Allergy Rhinol., 6, 737, 10.1002/alr.21735 · DOI · Paper page
  189. Chang, D., Garcia, R., Akers, K., Mende, K., Murray, C., Wenke, J., and Sanchez Jr., C. (2016). J. Activity of gallium meso- and protoporphyrin IX against biofilms of multidrug-resistant Acinetobacter baumannii isolates. Pharmaceuticals, 9. · DOI · Paper page
  190. Grunenwald, 2018, Nonconventional therapeutics against Staphylococcus aureus, Microbiol. Spectr., 6, 776, 10.1128/microbiolspec.GPP3-0047-2018 · DOI
  191. Thompson, 2015, Evaluation of gallium citrate formulations against a multidrug-resistant strain of Klebsiella pneumoniae in a murine wound model of infection, Antimicrob. Agents Chemother., 59, 6484, 10.1128/AAC.00882-15 · DOI
  192. Hijazi, 2017, Gallium-protoporphyrin IX inhibits Pseudomonas aeruginosa growth by targeting cytochromes, Front. Cell. Infect. Microbiol., 7, 1, 10.3389/fcimb.2017.00012 · DOI · Paper page
  193. Ramos, 2019, Antimicrobial activity and safety applications of meso-tetra(4-pyridyl)platinum(II) porphyrin, Microb. Pathog., 128, 47, 10.1016/j.micpath.2018.12.038 · DOI
  194. Managa, 2015, Photodynamic antimicrobial chemotherapy activity of gallium tetra-(4-carboxyphenyl) porphyrin when conjugated to differently shaped platinum nanoparticles, J. Mol. Struct., 1099, 432, 10.1016/j.molstruc.2015.06.077 · DOI
  195. Gianquinto, 2019, Interaction of human hemoglobin and semi-hemoglobins with the Staphylococcus aureus hemophore IsdB: A kinetic and mechanistic insight, Sci. Rep., 9, 18629, 10.1038/s41598-019-54970-w · DOI
  196. Ellis-Guardiola, K., Clayton, J., Pham, C., Mahoney, B.J., Wereszczynski, J., and Clubb, R.T. (2019). The Staphylococcus aureus IsdH receptor forms a dynamic complex with human hemoglobin that triggers heme release via two distinct hot spots. J. Mol. Biol. · DOI · Paper page
  197. Conger, 2017, Tight binding of heme to Staphylococcus aureus IsdG and IsdI precludes design of a competitive inhibitor, Metallomics, 9, 556, 10.1039/C7MT00035A · DOI
  198. Cascioferro, 2015, Sortase A inhibitors: Recent advances and future perspectives, J. Med. Chem., 58, 9108, 10.1021/acs.jmedchem.5b00779 · DOI
  199. Wang, G., Wang, X., Sun, L., Gao, Y., Niu, X., and Wang, H. (2018). Novel inhibitor discovery of Staphylococcus aureus sortase B and the mechanism confirmation via molecular modeling. Molecules, 23. · DOI
  200. Wang, 2018, Baicalin weakens Staphylococcus aureus pathogenicity by targeting sortase B, Front. Cell. Infect. Microbiol., 8, 418, 10.3389/fcimb.2018.00418 · DOI

200 of 226 shown

Cited by

See all 97

Metadata

Authors
Marchetti, M., De Bei, O., Bettati, S., Campanini, B., Kovachka, S., Gianquinto, E., Spyrakis, F., & Ronda, L.
Venue
International Journal of Molecular Sciences
Publisher
MDPI AG
Published
2020-03-20
Volume
21
Issue
6
Pages
2145
ISSN
1422-0067
Cited by
97
References
101
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.